Sinopharm Holdings: Sinopharm (CNCM LTD) reported a net profit attributable to shareholders of 949 million yuan in the first half of the year, a year-on-year decrease of 5.19%
I'm PortAI, I can summarize articles.
According to the Zhitong Finance APP, Sinopharm Holdings announced the performance of its subsidiary, SINOPHARM(CNCM LTD), for the first half of 2025, with operating revenue of approximately 25.634 billion yuan, a year-on-year increase of 3.54%. The net profit attributable to shareholders of the listed company was approximately 949 million yuan, a year-on-year decrease of 5.19%. The basic earnings per share were 1.2572 yuan
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments